Chemical and biological characterization of a polysaccharide biological response modifier from Aloe vera L. var. chinensis (Haw.) Berg.

被引:92
作者
Leung, MYK
Liu, C
Zhu, LF
Hui, YZ
Yu, B
Fung, KP [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China
[3] Chinese Acad Sci, S China Inst Bot, Guangzhou, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China
关键词
D O I
10.1093/glycob/cwh050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three purified polysaccharide fractions designated as PAC-I, PAC-II, and PAC-III were prepared from Aloe vera L. var. chinensis (Haw.) Berg. by membrane fractionation and gel filtration HPLC. The polysaccharide fractions had molecular weights of 10,000 kDa, 1300 kDa, and 470 kDa, respectively. The major sugar residue in the polysaccharide fractions is mannose, which was found to be91.5% in PAC-I, 87.9% in PAC-II, and 53.7% in PAC-III. The protein contents in the polysaccharide fractions was undetectable. NMR study of PAC-I and PAC-II demonstrated the polysaccharides shared the same structure. The main skeletons of PAC-I and PAC-II are beta-(1-->4)-D linked mannose with acetylation at C-6 of manopyranosyl. The polysaccharide fractions stimulated peritoneal macrophages, splenic T and B cell proliferation, and activated these cells to secrete TNF-alpha, IL-1beta, INF-gamma, IL-2, and IL-6. The polysaccharides were nontoxic and exhibited potent indirect antitumor response in murine model. PAC-I, which had the highest mannose content and molecular weight, was found to be the most potent biological response modifier of the three fractions. Our results suggested that the potency of aloe polysaccharide fraction increases as mannose content and molecular weight of the polysaccharide fraction increase.
引用
收藏
页码:501 / 510
页数:10
相关论文
共 40 条
[21]   Use of the best case series to evaluate complementary and alternative therapies for cancer: A systematic review [J].
Nahin, RL .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :552-562
[22]   A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth [J].
Niethammer, AG ;
Xiang, R ;
Becker, JC ;
Wodrich, H ;
Pertl, U ;
Karsten, G ;
Eliceiri, BP ;
Reisfeld, RA .
NATURE MEDICINE, 2002, 8 (12) :1369-1375
[23]  
Nose M, 1998, BIOL PHARM BULL, V21, P1110, DOI 10.1248/bpb.21.1110
[24]   Complementary and alternative therapies in prostate cancer [J].
Oh, WK ;
Small, EJ .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :575-584
[25]  
Pongnikorn Surathat, 2003, J Med Assoc Thai, V86, P61
[26]   Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: A novel treatment for experimental malignant glioma [J].
Rhines, LD ;
Sampath, P ;
DiMeco, F ;
Lawson, HC ;
Tyler, BM ;
Hanes, J ;
Olivi, A ;
Brem, H .
NEUROSURGERY, 2003, 52 (04) :872-879
[27]   Progress in human tumour immunology and immunotherapy [J].
Rosenberg, SA .
NATURE, 2001, 411 (6835) :380-384
[28]   Induction of cell death by radiotherapy [J].
Ross, GM .
ENDOCRINE-RELATED CANCER, 1999, 6 (01) :41-44
[29]   Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7 [J].
Ruiz-Bravo, A ;
Jimenez-Valera, M ;
Moreno, E ;
Guerra, V ;
Ramos-Cormenzana, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (04) :706-710
[30]   INTERLEUKIN-6 GENE-EXPRESSION AND PRODUCTION INDUCED IN HUMAN MONOCYTES BY MEMBRANE PROTEOGLYCANS FROM KLEBSIELLA-PNEUMONIAE [J].
SIRONI, M ;
SICA, A ;
RIGANTI, F ;
LICCIARDELLO, L ;
COLOTTA, F ;
MANTOVANI, A .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (04) :397-402